This Biotech Stock 135% Jump Trims $44M: What Now Today
A biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
Value-oriented index funds offer efficient exposure for retirement accounts. Review 2024 picks and what to check before investing.
24,226 articlesA biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
CareTrust's Q1 2026 earnings reveal steady cash flow and rising occupancy. This article breaks down what the numbers ...
Investors eye the Fennec Q1 2026 call to gauge milestones, cash runway, and potential catalysts. This guide breaks do...
Bezos pushes back on Mamdani’s tactic of painting opponents as villains, arguing real solutions require skill. The NY...
Curious about what the Agilent 2026 earnings call means for investors? This article breaks down the key takeaways, po...
Palantir (PLTR) sits near $152 after a blowout Q1 2026. Investors weigh whether to buy, hold, or sell Palantir stock ...
Intel shares jumped on a new Hitachi pact, fueling speculation that Google and NVIDIA could lean on Intel Foundry for...
Rumors of a SpaceX public offering sparked a dramatic surge in crypto derivatives on Hyperliquid, with the SPCX perpe...
In many American cities, affordable homes and Section 8 properties are hard to find. This in-depth guide explains why...
Two fast-food giants shape the investing landscape with very different revenue engines. This analysis dives into how ...
A headline generating deal points to a new era for Bitcoin miners. This guide breaks down why bitcoin mining stocks j...
As 2026 unfolds, investors face a choice between StubHub's fast-growing digital ticketing platform and Build-A-Bear's...